BioSpace News Archive

Aptevo Therapeutics Inc. and Alligator Bioscience provided an update on ALG.APV-527, a novel immunotherapeutic bispecific candidate intended for the treatment of multiple solid tumors expressing 5T4, a tumor-restricted antigen.

Ventus Therapeutics, a biopharmaceutical company with proprietary technologies for structure-enabled small-molecule drug discovery that is developing medicines targeting the innate immune system, announced that it has been selected as one of 10 Start-Ups to Watch by Chemical & Engineering News.

Halberd Corporation Chairman, President and CEO, William A. Hartman, was interviewed recently by host, Donald Baillargeon, on Money TV.

PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced that it has been granted U.S. Patent No. 10,828,364 titled “Method for Reducing a Myeloid Derived Suppressor Cell Population With Cationic Lipid Vaccine Compositions” by the United States Patent and Tr

NuProbe, an innovator of genomics and molecular diagnostics technologies, announces the launch of the Augury™ platform for automated design of customized liquid biopsy NGS panels.

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) (“Titan” or the “Company”) today reported financial results for the third quarter ended September 30, 2020 and provided an update on its business.

Acquisition Expands Medtronic’s Artificial Intelligence and Data Capabilities, Becoming the First Company to Offer an Integrated Spine Solution Including AI-Driven Surgical Planning, Personalized Spinal Implants and Robotic Assisted Surgery

Cancer patients who self-administer their therapy can now better manage their care online, thanks to the latest digital clinical assessment available only through AllianceRx Walgreens Prime.

EpiBone, Inc., a privately held, clinical-stage regenerative medicine company focused on skeletal reconstruction, announced today the appointment of Robert S. Langer, Sc.D., to its Board of Directors.

In an unprecedented collaboration designed to speed research advances, Duchenne UK, the Muscular Dystrophy Association (MDA) and Parent Project Muscular Dystrophy (PPMD) have announced a joint grant of $686,500 to Dr. William Evans (principal investigators